These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24657963)

  • 21. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
    Gao Y; Chu SF; Li JP; Zhang Z; Yan JQ; Wen ZL; Xia CY; Mou Z; Wang ZZ; He WB; Guo XF; Wei GN; Chen NH
    Acta Pharmacol Sin; 2015 Mar; 36(3):311-22. PubMed ID: 25640478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
    Mehan S; Monga V; Rani M; Dudi R; Ghimire K
    Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum.
    Yang X; Chu SF; Wang ZZ; Li FF; Yuan YH; Chen NH
    Acta Pharmacol Sin; 2021 Sep; 42(9):1409-1421. PubMed ID: 33214696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.
    Garcia M; Vanhoutte P; Pages C; Besson MJ; Brouillet E; Caboche J
    J Neurosci; 2002 Mar; 22(6):2174-84. PubMed ID: 11896157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways.
    Elbaz EM; Helmy HS; El-Sahar AE; Saad MA; Sayed RH
    Neurochem Int; 2019 Dec; 131():104548. PubMed ID: 31539560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease.
    Kumar P; Kalonia H; Kumar A
    Behav Pharmacol; 2010 May; 21(3):217-30. PubMed ID: 20480544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease.
    Chakraborty J; Singh R; Dutta D; Naskar A; Rajamma U; Mohanakumar KP
    CNS Neurosci Ther; 2014 Jan; 20(1):10-9. PubMed ID: 24188794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrastriatal 3-nitropropionic acid: a behavioral assessment.
    Koutouzis TK; Borlongan CV; Freeman TB; Cahill DW; Sanberg PR
    Neuroreport; 1994 Nov; 5(17):2241-5. PubMed ID: 7881036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats.
    Wells RG; Azzam AF; Hiller AL; Sardinia MF
    J Huntingtons Dis; 2024; 13(1):55-66. PubMed ID: 38489193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-ivabradine averts behavioral anomalies in Huntington's disease rat model via modulating Rhes/m-tor pathway.
    Saad MA; Ahmed MAE; Elbadawy NN; Abdelkader NF
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110368. PubMed ID: 34087391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein regulation of induced pluripotent stem cells by transplanting in a Huntington's animal model.
    Mu S; Han L; Zhou G; Mo C; Duan J; He Z; Wang Z; Ren L; Zhang J
    Neuropathol Appl Neurobiol; 2016 Oct; 42(6):521-34. PubMed ID: 26859760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
    Vis JC; Verbeek MM; De Waal RM; Ten Donkelaar HJ; Kremer HP
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):513-21. PubMed ID: 10632901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective effects of levothyroxine on cognition deficits and memory in an experimental model of Huntington's disease in rats: An electrophysiological study.
    Badini F; Mirshekar MA; Shahraki S; Fanaei H; Bayrami A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5939-5951. PubMed ID: 38372755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
    Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
    J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
    Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.
    Liu L; Huang JS; Han C; Zhang GX; Xu XY; Shen Y; Li J; Jiang HY; Lin ZC; Xiong N; Wang T
    Mol Neurobiol; 2016 Dec; 53(10):6698-6708. PubMed ID: 26659595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease.
    Tsang TM; Haselden JN; Holmes E
    Neurochem Res; 2009 Jul; 34(7):1261-71. PubMed ID: 19148750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.
    Yuan T; Liao W; Feng NH; Lou YL; Niu X; Zhang AJ; Wang Y; Deng ZF
    Stem Cell Res Ther; 2013 Jun; 4(3):73. PubMed ID: 23769173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease.
    Al-Gharaibeh A; Culver R; Stewart AN; Srinageshwar B; Spelde K; Frollo L; Kolli N; Story D; Paladugu L; Anwar S; Crane A; Wyse R; Maiti P; Dunbar GL; Rossignol J
    Front Neurosci; 2017; 11():628. PubMed ID: 29209158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.